Your browser doesn't support javascript.
loading
Knockdown of POLQ interferes the development and progression of hepatocellular carcinoma through regulating cell proliferation, apoptosis and migration.
Pan, Qi; Wang, Lu; Liu, Yu; Li, Min; Zhang, Yao; Peng, Wei; Deng, Tan; Peng, Mei-Ling; Jiang, Jin-Qiong; Tang, Jiao; Wang, Jingjing; Duan, Hua-Xin; Fan, Sha-Sha.
Affiliation
  • Pan Q; Department of Hepatic Surgery, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Wang L; Department of Hepatic Surgery, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Liu Y; Department of Pathology, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Changsha, 410000, Hunan, China.
  • Li M; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China.
  • Zhang Y; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China.
  • Peng W; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China.
  • Deng T; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China.
  • Peng ML; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China.
  • Jiang JQ; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China.
  • Tang J; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China.
  • Wang J; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, 410000, Hunan, China.
  • Duan HX; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China. duanhuaxin@hunnu.edu.cn.
  • Fan SS; Oncology Department, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, 410000, Hunan, China. shashafan0225@hunnu.edu.cn.
Cancer Cell Int ; 21(1): 482, 2021 Sep 13.
Article in En | MEDLINE | ID: mdl-34517891
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Cell Int Year: 2021 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Cell Int Year: 2021 Type: Article Affiliation country: China